Gene · 23239
Papers1,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases. | Front Immunol | 2022 | 35185900 | PubTator, text mining | PubMed |
| Lift the Veil of Breast Cancers Using 4 or Fewer Critical Genes. | Cancer Inform | 2022 | 35185329 | PubTator, text mining | PubMed |
| Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-β Signaling Axis in Pancreatic Cancer. | Gastroenterology | 2022 | 35176309 | PubTator, text mining | PubMed |
Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression. | Bioengineered | 2022 | 35164653 | PubTator, text mining | PubMed |
| Genome-Wide Identification of Histone Modification Gene Families in the Model Legume Medicago truncatula and Their Expression Analysis in Nodules. | Plants (Basel) | 2022 | 35161303 | PubTator, text mining | PubMed |
| New Insights into the Mechanisms of Chaperon-Mediated Autophagy and Implications for Kidney Diseases. | Cells | 2022 | 35159216 | PubTator, text mining | PubMed |
| UCHL1 Promoted Polarization of M1 Macrophages by Regulating the PI3K/AKT Signaling Pathway. | J Inflamm Res | 2022 | 35153498 | PubTator, text mining | PubMed |
| PHLPP1 deficiency ameliorates cardiomyocyte death and cardiac dysfunction through inhibiting Mcl-1 degradation. | Cell Signal | 2022 | 35151832 | PubTator, text mining | PubMed |
| RAS-mediated tumor stress adaptation and the targeting opportunities it presents. | Dis Model Mech | 2022 | 35147163 | PubTator, text mining | PubMed |
| PHLPP1 promotes neutral lipid accumulation through AMPK/ChREBP-dependent lipid uptake and fatty acid synthesis pathways. | iScience | 2022 | 35141506 | PubTator, text mining | PubMed |
| PHLPP1 deletion restores pancreatic β-cell survival and normoglycemia in the db/db mouse model of obesity-associated diabetes. | Cell Death Discov | 2022 | 35136063 | PubTator, text mining | PubMed |
| The different autophagy degradation pathways and neurodegeneration. | Neuron | 2022 | 35134347 | PubTator, text mining | PubMed |
| Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma. | J Oncol | 2022 | 35126514 | PubTator, text mining | PubMed |
| Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer. | Mol Cancer Res | 2022 | 35105671 | PubTator, text mining | PubMed |
| ZBTB11 dysfunction: spectrum of brain abnormalities, biochemical signature and cellular consequences. | Brain | 2022 | 35104841 | PubTator, text mining | PubMed |
| Potential roles of hsa_circ_000839 and hsa_circ_0005986 in breast cancer. | J Clin Lab Anal | 2022 | 35098570 | PubTator, text mining | PubMed |
| miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling. | Cancer Cell Int | 2022 | 35090460 | PubTator, text mining | PubMed |
| Effect of Smoking and Its Cessation on the Transcript Profile of Peripheral Monocytes in COPD Patients. | Int J Chron Obstruct Pulmon Dis | 2022 | 35027824 | PubTator, text mining | PubMed |
| PHLPP1 Overexpression was Associated With a Good Prognosis With Decreased AKT Activity in Gastric Cancer. | Technol Cancer Res Treat | 2022 | 34982011 | PubTator, text mining | PubMed |
| LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways. | J Cancer | 2022 | 34976187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23239/papers?page=18